Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Angiography | 38 | 2020 | 1285 | 7.140 |
Why?
|
Cerebral Hemorrhage | 40 | 2023 | 2647 | 4.770 |
Why?
|
Carotid Stenosis | 12 | 2022 | 854 | 1.910 |
Why?
|
Hematoma | 16 | 2020 | 758 | 1.910 |
Why?
|
Tomography, X-Ray Computed | 50 | 2023 | 20129 | 1.680 |
Why?
|
Cerebrovascular Disorders | 6 | 2023 | 1504 | 1.670 |
Why?
|
Magnetic Resonance Angiography | 11 | 2023 | 1442 | 1.610 |
Why?
|
Aneurysm, Ruptured | 4 | 2020 | 452 | 1.410 |
Why?
|
Intracranial Hemorrhages | 7 | 2023 | 855 | 1.290 |
Why?
|
Intracranial Aneurysm | 5 | 2020 | 1197 | 1.130 |
Why?
|
Carotid Arteries | 6 | 2017 | 952 | 1.080 |
Why?
|
Stroke | 25 | 2023 | 9981 | 1.060 |
Why?
|
Carotid Artery, Internal | 8 | 2022 | 445 | 1.040 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 3 | 2016 | 105 | 0.950 |
Why?
|
Tomography, Spiral Computed | 5 | 2014 | 280 | 0.930 |
Why?
|
Microscopic Polyangiitis | 1 | 2023 | 45 | 0.910 |
Why?
|
Churg-Strauss Syndrome | 1 | 2023 | 70 | 0.890 |
Why?
|
Angiography, Digital Subtraction | 3 | 2019 | 341 | 0.780 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2020 | 475 | 0.770 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2019 | 42 | 0.700 |
Why?
|
Hospital Mortality | 9 | 2016 | 5317 | 0.670 |
Why?
|
Intracranial Thrombosis | 1 | 2020 | 113 | 0.660 |
Why?
|
Biota | 1 | 2018 | 22 | 0.650 |
Why?
|
Seaweed | 1 | 2018 | 28 | 0.640 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2018 | 36 | 0.630 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2019 | 138 | 0.620 |
Why?
|
Contrast Media | 12 | 2020 | 5300 | 0.600 |
Why?
|
Thrombectomy | 1 | 2022 | 680 | 0.580 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2013 | 205 | 0.560 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2016 | 292 | 0.540 |
Why?
|
Sensitivity and Specificity | 22 | 2020 | 14722 | 0.540 |
Why?
|
Fishes | 1 | 2018 | 569 | 0.510 |
Why?
|
Thrombotic Microangiopathies | 1 | 2016 | 132 | 0.500 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2020 | 1184 | 0.490 |
Why?
|
Neck Injuries | 2 | 2010 | 152 | 0.490 |
Why?
|
Angiography | 4 | 2022 | 1639 | 0.480 |
Why?
|
Vasa Vasorum | 1 | 2013 | 26 | 0.470 |
Why?
|
Aged, 80 and over | 39 | 2022 | 57776 | 0.470 |
Why?
|
Hematoma, Subdural, Intracranial | 2 | 2014 | 33 | 0.460 |
Why?
|
Echoencephalography | 1 | 2014 | 135 | 0.460 |
Why?
|
Carotid Artery Diseases | 4 | 2017 | 882 | 0.450 |
Why?
|
Cranial Fossa, Posterior | 1 | 2014 | 139 | 0.450 |
Why?
|
Aged | 62 | 2023 | 163280 | 0.450 |
Why?
|
Diagnostic Imaging | 5 | 2023 | 3507 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 22 | 2023 | 35421 | 0.430 |
Why?
|
Antihypertensive Agents | 5 | 2021 | 2046 | 0.420 |
Why?
|
Nervous System Diseases | 4 | 2019 | 1622 | 0.420 |
Why?
|
Hematoma, Subdural | 1 | 2013 | 126 | 0.420 |
Why?
|
Middle Aged | 62 | 2022 | 213383 | 0.400 |
Why?
|
Craniocerebral Trauma | 2 | 2010 | 482 | 0.390 |
Why?
|
Humans | 124 | 2023 | 744343 | 0.390 |
Why?
|
Posthumous Conception | 1 | 2010 | 11 | 0.380 |
Why?
|
Image Enhancement | 2 | 2017 | 2921 | 0.380 |
Why?
|
Retrospective Studies | 42 | 2023 | 77449 | 0.380 |
Why?
|
Ischemic Attack, Transient | 3 | 2022 | 935 | 0.380 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2023 | 2737 | 0.370 |
Why?
|
Third-Party Consent | 1 | 2010 | 64 | 0.370 |
Why?
|
Male | 76 | 2023 | 350118 | 0.360 |
Why?
|
Hypoxia, Brain | 1 | 2010 | 133 | 0.350 |
Why?
|
Cerebral Veins | 1 | 2011 | 156 | 0.350 |
Why?
|
Perfusion Imaging | 1 | 2011 | 195 | 0.350 |
Why?
|
Wounds, Nonpenetrating | 3 | 2010 | 794 | 0.350 |
Why?
|
Respiratory Paralysis | 1 | 2009 | 31 | 0.340 |
Why?
|
Predictive Value of Tests | 17 | 2016 | 15076 | 0.340 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2010 | 103 | 0.340 |
Why?
|
Female | 72 | 2023 | 380194 | 0.340 |
Why?
|
Oocyte Retrieval | 1 | 2010 | 161 | 0.340 |
Why?
|
Head Injuries, Closed | 1 | 2010 | 136 | 0.340 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2017 | 8949 | 0.340 |
Why?
|
Cerebral Infarction | 2 | 2006 | 1011 | 0.330 |
Why?
|
Phlebography | 1 | 2010 | 333 | 0.330 |
Why?
|
Mediterranean Sea | 3 | 2018 | 12 | 0.330 |
Why?
|
Skull Fractures | 1 | 2010 | 195 | 0.330 |
Why?
|
Radiographic Image Enhancement | 3 | 2014 | 885 | 0.310 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 481 | 0.310 |
Why?
|
Algorithms | 7 | 2023 | 13881 | 0.310 |
Why?
|
Observer Variation | 8 | 2017 | 2593 | 0.300 |
Why?
|
Middle Cerebral Artery | 3 | 2016 | 264 | 0.290 |
Why?
|
Brain Diseases | 2 | 2014 | 1563 | 0.290 |
Why?
|
Imaging, Three-Dimensional | 3 | 2020 | 4042 | 0.280 |
Why?
|
Vascular Diseases | 2 | 2019 | 1161 | 0.280 |
Why?
|
Tracheostomy | 1 | 2009 | 401 | 0.260 |
Why?
|
ROC Curve | 8 | 2022 | 3527 | 0.260 |
Why?
|
Ultrasonography | 2 | 2019 | 5985 | 0.260 |
Why?
|
Brain | 12 | 2019 | 26385 | 0.250 |
Why?
|
Cerebral Arterial Diseases | 2 | 2023 | 82 | 0.250 |
Why?
|
Reproducibility of Results | 14 | 2023 | 19905 | 0.240 |
Why?
|
Risk Factors | 21 | 2023 | 72290 | 0.240 |
Why?
|
Adult | 36 | 2021 | 214055 | 0.240 |
Why?
|
Nicardipine | 2 | 2021 | 60 | 0.230 |
Why?
|
Stents | 2 | 2013 | 3280 | 0.220 |
Why?
|
Endarterectomy, Carotid | 2 | 2022 | 546 | 0.220 |
Why?
|
Central Nervous System Neoplasms | 2 | 2021 | 895 | 0.220 |
Why?
|
Pneumocephalus | 1 | 2023 | 46 | 0.210 |
Why?
|
Brain Ischemia | 4 | 2017 | 3265 | 0.210 |
Why?
|
Models, Theoretical | 1 | 2014 | 3589 | 0.210 |
Why?
|
Arterial Occlusive Diseases | 3 | 2016 | 793 | 0.210 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 288 | 0.200 |
Why?
|
Spinal Cord Injuries | 1 | 2009 | 931 | 0.200 |
Why?
|
Arteries | 2 | 2023 | 1119 | 0.200 |
Why?
|
Adolescent | 16 | 2019 | 85781 | 0.190 |
Why?
|
Vision Disorders | 2 | 2021 | 1058 | 0.190 |
Why?
|
Prognosis | 14 | 2018 | 29063 | 0.180 |
Why?
|
Ultrasonography, Doppler | 1 | 2002 | 458 | 0.180 |
Why?
|
Young Adult | 15 | 2019 | 56430 | 0.180 |
Why?
|
Acute Disease | 6 | 2018 | 7149 | 0.180 |
Why?
|
Disease Progression | 10 | 2020 | 13284 | 0.180 |
Why?
|
Hypertension | 1 | 2019 | 8480 | 0.170 |
Why?
|
Severity of Illness Index | 10 | 2016 | 15540 | 0.170 |
Why?
|
Basilar Artery | 2 | 2015 | 200 | 0.170 |
Why?
|
Echo-Planar Imaging | 2 | 2023 | 659 | 0.170 |
Why?
|
Spain | 2 | 2018 | 465 | 0.170 |
Why?
|
Diagnosis, Differential | 9 | 2021 | 12959 | 0.170 |
Why?
|
Marine Biology | 1 | 2018 | 18 | 0.170 |
Why?
|
Glasgow Coma Scale | 4 | 2017 | 570 | 0.170 |
Why?
|
Leukoaraiosis | 1 | 2020 | 120 | 0.160 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1107 | 0.160 |
Why?
|
Perfusion | 2 | 2022 | 1360 | 0.160 |
Why?
|
Respiration, Artificial | 1 | 2009 | 2569 | 0.160 |
Why?
|
Glyburide | 1 | 2018 | 113 | 0.160 |
Why?
|
Geologic Sediments | 2 | 2017 | 77 | 0.160 |
Why?
|
Bivalvia | 1 | 2017 | 53 | 0.160 |
Why?
|
Plaque, Atherosclerotic | 3 | 2019 | 1519 | 0.150 |
Why?
|
Emergency Medical Services | 1 | 2009 | 1917 | 0.150 |
Why?
|
Multivariate Analysis | 9 | 2020 | 12245 | 0.150 |
Why?
|
Herpesvirus 3, Human | 1 | 2018 | 204 | 0.150 |
Why?
|
Ultrasonography, Doppler, Color | 2 | 2015 | 233 | 0.140 |
Why?
|
Hemorrhage | 1 | 2009 | 3461 | 0.140 |
Why?
|
Databases as Topic | 1 | 2018 | 475 | 0.140 |
Why?
|
Early Termination of Clinical Trials | 1 | 2016 | 68 | 0.140 |
Why?
|
Fibrinolytic Agents | 3 | 2022 | 2158 | 0.140 |
Why?
|
Incidence | 6 | 2017 | 20947 | 0.140 |
Why?
|
Gerstmann Syndrome | 1 | 2016 | 4 | 0.140 |
Why?
|
Child | 11 | 2019 | 77709 | 0.140 |
Why?
|
Apolipoproteins E | 2 | 2012 | 1438 | 0.140 |
Why?
|
Plasminogen Activators | 1 | 2016 | 209 | 0.140 |
Why?
|
Metals, Heavy | 1 | 2017 | 139 | 0.140 |
Why?
|
Cohort Studies | 13 | 2018 | 40561 | 0.140 |
Why?
|
Circle of Willis | 1 | 2015 | 68 | 0.130 |
Why?
|
Anterior Cerebral Artery | 1 | 2015 | 48 | 0.130 |
Why?
|
Herpes Zoster | 1 | 2018 | 264 | 0.130 |
Why?
|
Blood-Brain Barrier | 1 | 2002 | 1017 | 0.130 |
Why?
|
Blood Pressure | 4 | 2021 | 8554 | 0.130 |
Why?
|
Hypocalcemia | 1 | 2016 | 191 | 0.130 |
Why?
|
Warfarin | 3 | 2014 | 1496 | 0.130 |
Why?
|
Pons | 1 | 2016 | 245 | 0.130 |
Why?
|
Survival Rate | 6 | 2013 | 12788 | 0.130 |
Why?
|
Causality | 2 | 2013 | 1275 | 0.130 |
Why?
|
Water Movements | 1 | 2014 | 17 | 0.130 |
Why?
|
Single-Blind Method | 2 | 2015 | 1590 | 0.120 |
Why?
|
Time Factors | 8 | 2017 | 40075 | 0.120 |
Why?
|
Teleradiology | 1 | 2014 | 53 | 0.120 |
Why?
|
Apolipoprotein E2 | 2 | 2012 | 127 | 0.120 |
Why?
|
Central Nervous System Infections | 1 | 2014 | 56 | 0.120 |
Why?
|
Avitaminosis | 1 | 2014 | 34 | 0.120 |
Why?
|
Brain Edema | 1 | 2018 | 617 | 0.120 |
Why?
|
Blood Cells | 1 | 2016 | 309 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1381 | 0.120 |
Why?
|
Water Pollutants, Chemical | 1 | 2017 | 311 | 0.120 |
Why?
|
Moyamoya Disease | 1 | 2016 | 238 | 0.120 |
Why?
|
Research Design | 1 | 2009 | 5987 | 0.120 |
Why?
|
Climate | 1 | 2014 | 147 | 0.110 |
Why?
|
Incidental Findings | 1 | 2018 | 689 | 0.110 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2016 | 356 | 0.110 |
Why?
|
Ecosystem | 1 | 2017 | 474 | 0.110 |
Why?
|
Radiography | 4 | 2014 | 7023 | 0.110 |
Why?
|
Craniopharyngioma | 1 | 2015 | 281 | 0.110 |
Why?
|
Area Under Curve | 3 | 2014 | 1654 | 0.110 |
Why?
|
Logistic Models | 7 | 2020 | 13408 | 0.110 |
Why?
|
Conservation of Natural Resources | 1 | 2014 | 204 | 0.100 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2014 | 472 | 0.100 |
Why?
|
Prospective Studies | 10 | 2022 | 53288 | 0.100 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 941 | 0.100 |
Why?
|
Radiology, Interventional | 1 | 2016 | 460 | 0.100 |
Why?
|
Child, Preschool | 7 | 2019 | 41006 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1052 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3508 | 0.100 |
Why?
|
Anticoagulants | 4 | 2022 | 4599 | 0.100 |
Why?
|
Penis | 1 | 2012 | 216 | 0.100 |
Why?
|
False Positive Reactions | 1 | 2014 | 981 | 0.100 |
Why?
|
Brazil | 1 | 2015 | 1270 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2014 | 638 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 657 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 413 | 0.090 |
Why?
|
Treatment Outcome | 13 | 2022 | 63114 | 0.090 |
Why?
|
Ethics Committees, Clinical | 1 | 2010 | 56 | 0.090 |
Why?
|
Odds Ratio | 4 | 2018 | 9849 | 0.090 |
Why?
|
Patient Admission | 2 | 2012 | 1380 | 0.090 |
Why?
|
Blood Loss, Surgical | 1 | 2014 | 662 | 0.090 |
Why?
|
Biopsy | 2 | 2019 | 6756 | 0.090 |
Why?
|
Follow-Up Studies | 9 | 2016 | 39050 | 0.090 |
Why?
|
Infant | 6 | 2019 | 35136 | 0.090 |
Why?
|
Washington | 1 | 2010 | 313 | 0.090 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 461 | 0.090 |
Why?
|
Brucella melitensis | 1 | 2008 | 7 | 0.090 |
Why?
|
Catheters, Indwelling | 1 | 2012 | 426 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2020 | 3327 | 0.080 |
Why?
|
Jugular Veins | 1 | 2010 | 204 | 0.080 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 441 | 0.080 |
Why?
|
Brucellosis | 1 | 2008 | 20 | 0.080 |
Why?
|
Boston | 2 | 2013 | 9313 | 0.080 |
Why?
|
Comparative Effectiveness Research | 1 | 2014 | 681 | 0.080 |
Why?
|
Educational Measurement | 1 | 2016 | 1210 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3703 | 0.080 |
Why?
|
Carotid Artery, Common | 1 | 2009 | 183 | 0.080 |
Why?
|
Eye Diseases | 2 | 2021 | 669 | 0.080 |
Why?
|
Hospitals, General | 1 | 2013 | 749 | 0.080 |
Why?
|
Risk Assessment | 6 | 2018 | 23338 | 0.080 |
Why?
|
Behcet Syndrome | 1 | 2009 | 84 | 0.080 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 234 | 0.080 |
Why?
|
Environment | 1 | 2014 | 1124 | 0.080 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2013 | 1018 | 0.080 |
Why?
|
Intracranial Hypertension | 1 | 2010 | 186 | 0.080 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1018 | 0.080 |
Why?
|
Epidural Abscess | 1 | 2008 | 84 | 0.080 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 114 | 0.070 |
Why?
|
Polychondritis, Relapsing | 1 | 2007 | 28 | 0.070 |
Why?
|
Artifacts | 2 | 2023 | 1904 | 0.070 |
Why?
|
Tracheal Stenosis | 1 | 2009 | 226 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 1345 | 0.070 |
Why?
|
Vasculitis | 2 | 2009 | 519 | 0.070 |
Why?
|
Survival Analysis | 2 | 2016 | 10252 | 0.070 |
Why?
|
Cerebrovascular Circulation | 2 | 2010 | 2731 | 0.070 |
Why?
|
Withholding Treatment | 1 | 2010 | 599 | 0.070 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2009 | 274 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 2012 | 2400 | 0.070 |
Why?
|
Ear Diseases | 1 | 2007 | 170 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2043 | 0.070 |
Why?
|
Cryopreservation | 1 | 2010 | 670 | 0.070 |
Why?
|
Vertebral Artery | 1 | 2006 | 192 | 0.060 |
Why?
|
Comorbidity | 3 | 2017 | 10388 | 0.060 |
Why?
|
Collateral Circulation | 1 | 2005 | 287 | 0.060 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2014 | 1186 | 0.060 |
Why?
|
Infant, Premature | 1 | 2014 | 2044 | 0.060 |
Why?
|
Mutation | 2 | 2021 | 29786 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.060 |
Why?
|
Gadolinium | 1 | 2009 | 952 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2014 | 7659 | 0.060 |
Why?
|
Mammography | 1 | 2014 | 2476 | 0.060 |
Why?
|
Trachea | 1 | 2009 | 1076 | 0.060 |
Why?
|
Optic Nerve | 2 | 2021 | 554 | 0.060 |
Why?
|
Calcium | 1 | 2016 | 5756 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2009 | 834 | 0.060 |
Why?
|
Thrombolytic Therapy | 2 | 2013 | 2161 | 0.060 |
Why?
|
Cerebrospinal Fluid | 2 | 2021 | 534 | 0.060 |
Why?
|
Functional Laterality | 1 | 2010 | 2290 | 0.060 |
Why?
|
Penile Erection | 2 | 2013 | 97 | 0.050 |
Why?
|
Testosterone | 1 | 2013 | 2420 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3605 | 0.050 |
Why?
|
Malaria, Falciparum | 1 | 2011 | 1077 | 0.050 |
Why?
|
Hypoventilation | 1 | 2001 | 38 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6459 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2703 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2010 | 1912 | 0.050 |
Why?
|
Viscera | 1 | 2002 | 139 | 0.050 |
Why?
|
Environmental Monitoring | 2 | 2017 | 1414 | 0.050 |
Why?
|
Myosin Heavy Chains | 1 | 2023 | 414 | 0.050 |
Why?
|
Intubation, Intratracheal | 1 | 2009 | 1364 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2011 | 1732 | 0.050 |
Why?
|
Eye Pain | 1 | 2021 | 47 | 0.050 |
Why?
|
Prevalence | 4 | 2013 | 15226 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3610 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6933 | 0.050 |
Why?
|
Occupational Diseases | 1 | 2008 | 1471 | 0.050 |
Why?
|
Heart Arrest | 1 | 2010 | 1470 | 0.050 |
Why?
|
Skin | 1 | 2014 | 4364 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2021 | 403 | 0.040 |
Why?
|
Diffusion | 1 | 2002 | 833 | 0.040 |
Why?
|
Calcinosis | 1 | 2009 | 1499 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 13033 | 0.040 |
Why?
|
Reference Standards | 2 | 2015 | 1025 | 0.040 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2002 | 501 | 0.040 |
Why?
|
Abdominal Injuries | 1 | 2002 | 352 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2010 | 280 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2002 | 596 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 734 | 0.040 |
Why?
|
Veins | 1 | 2002 | 770 | 0.040 |
Why?
|
Tuberculosis | 2 | 2008 | 1912 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2010 | 2376 | 0.040 |
Why?
|
Trauma Centers | 1 | 2002 | 890 | 0.040 |
Why?
|
Ecology | 1 | 2017 | 106 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15165 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9239 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 354 | 0.040 |
Why?
|
Optic Disk | 1 | 2021 | 400 | 0.040 |
Why?
|
Acute Kidney Injury | 1 | 2009 | 1972 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 7913 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2009 | 3679 | 0.030 |
Why?
|
Length of Stay | 1 | 2009 | 6309 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12072 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2022 | 3068 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2018 | 601 | 0.030 |
Why?
|
Adenine | 1 | 2021 | 936 | 0.030 |
Why?
|
Animals | 3 | 2018 | 168757 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1357 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 8863 | 0.030 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 1997 | 303 | 0.030 |
Why?
|
Iodine | 1 | 2017 | 286 | 0.030 |
Why?
|
Hematologic Tests | 1 | 2016 | 240 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2014 | 25625 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2011 | 5708 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11524 | 0.030 |
Why?
|
Speech Disorders | 1 | 2016 | 189 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 816 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2002 | 1073 | 0.030 |
Why?
|
Ascorbic Acid Deficiency | 1 | 2014 | 24 | 0.030 |
Why?
|
Fractals | 1 | 2014 | 123 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 311 | 0.030 |
Why?
|
Valine | 1 | 2015 | 413 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21683 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2002 | 1488 | 0.030 |
Why?
|
Patient Simulation | 1 | 2016 | 309 | 0.030 |
Why?
|
Vitamin A Deficiency | 1 | 2014 | 101 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 371 | 0.030 |
Why?
|
Genotype | 3 | 2012 | 12951 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2018 | 921 | 0.030 |
Why?
|
Piperidines | 1 | 2021 | 1602 | 0.030 |
Why?
|
Aortic Valve | 1 | 2002 | 1922 | 0.030 |
Why?
|
Problem-Based Learning | 1 | 2016 | 361 | 0.030 |
Why?
|
Hemodynamics | 1 | 2002 | 4199 | 0.030 |
Why?
|
Pain | 2 | 2021 | 4986 | 0.030 |
Why?
|
Coitus | 1 | 2012 | 133 | 0.030 |
Why?
|
Point-of-Care Systems | 2 | 2011 | 1177 | 0.030 |
Why?
|
Aorta, Abdominal | 1 | 2014 | 646 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 729 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 16718 | 0.020 |
Why?
|
Recurrence | 1 | 2023 | 8340 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 712 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 973 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17446 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2012 | 2716 | 0.020 |
Why?
|
Peripheral Vascular Diseases | 1 | 2013 | 550 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1169 | 0.020 |
Why?
|
Software | 2 | 2017 | 4443 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1656 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2011 | 364 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 986 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 917 | 0.020 |
Why?
|
Brain Stem | 1 | 2014 | 846 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1206 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2480 | 0.020 |
Why?
|
Exanthema | 1 | 2014 | 501 | 0.020 |
Why?
|
Reperfusion | 1 | 2010 | 284 | 0.020 |
Why?
|
Genital Diseases, Male | 1 | 2009 | 84 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 2 | 2009 | 1790 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2010 | 367 | 0.020 |
Why?
|
Headache | 1 | 2016 | 1226 | 0.020 |
Why?
|
Apolipoprotein E4 | 1 | 2012 | 668 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 21746 | 0.020 |
Why?
|
Erythema | 1 | 2009 | 257 | 0.020 |
Why?
|
Vasospasm, Intracranial | 1 | 2010 | 208 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 1504 | 0.020 |
Why?
|
Otitis Externa | 1 | 2007 | 19 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.020 |
Why?
|
Neck Pain | 1 | 2008 | 180 | 0.020 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2006 | 16 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 20822 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
Bacteria | 1 | 2017 | 2114 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6538 | 0.020 |
Why?
|
Nose Diseases | 1 | 2007 | 79 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1814 | 0.020 |
Why?
|
Ear | 1 | 2007 | 173 | 0.020 |
Why?
|
Demyelinating Diseases | 1 | 2009 | 354 | 0.020 |
Why?
|
Tuberculosis, Meningeal | 1 | 2006 | 45 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2013 | 1261 | 0.020 |
Why?
|
Uganda | 1 | 2011 | 1243 | 0.020 |
Why?
|
Heart Block | 1 | 2007 | 410 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2454 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2014 | 1475 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 440 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2362 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2006 | 499 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2009 | 1850 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2886 | 0.010 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1343 | 0.010 |
Why?
|
Creatinine | 1 | 2009 | 1919 | 0.010 |
Why?
|
Night Care | 1 | 2002 | 28 | 0.010 |
Why?
|
Edema | 1 | 2007 | 789 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12354 | 0.010 |
Why?
|
Prednisone | 1 | 2007 | 1574 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6196 | 0.010 |
Why?
|
Endovascular Procedures | 1 | 2016 | 1979 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2008 | 975 | 0.010 |
Why?
|
Celiac Artery | 1 | 2002 | 69 | 0.010 |
Why?
|
After-Hours Care | 1 | 2002 | 102 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4456 | 0.010 |
Why?
|
Mesenteric Veins | 1 | 2002 | 89 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8089 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2003 | 635 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 2002 | 183 | 0.010 |
Why?
|
Fever | 1 | 2008 | 1616 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2009 | 880 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2013 | 3966 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11366 | 0.010 |
Why?
|
Vascular Patency | 1 | 2003 | 886 | 0.010 |
Why?
|
Wounds, Penetrating | 1 | 2002 | 307 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10397 | 0.010 |
Why?
|
Hypercapnia | 1 | 2001 | 260 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8663 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2003 | 1525 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2002 | 1014 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5535 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2010 | 2149 | 0.010 |
Why?
|
California | 1 | 2002 | 1402 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19229 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2008 | 1796 | 0.010 |
Why?
|
Sinusitis | 1 | 2007 | 923 | 0.010 |
Why?
|
DNA | 1 | 2012 | 7301 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8324 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2001 | 1423 | 0.010 |
Why?
|
Cuba | 1 | 1997 | 47 | 0.010 |
Why?
|
Vasodilation | 1 | 2001 | 944 | 0.010 |
Why?
|
Heart | 1 | 2011 | 4467 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 8987 | 0.010 |
Why?
|
HIV-1 | 1 | 2014 | 6939 | 0.010 |
Why?
|
Nutrition Disorders | 1 | 1997 | 211 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4149 | 0.010 |
Why?
|
Genetic Variation | 1 | 2011 | 6544 | 0.010 |
Why?
|
United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
Obesity | 2 | 2013 | 12745 | 0.010 |
Why?
|
Reference Values | 1 | 2001 | 4982 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25043 | 0.010 |
Why?
|
Anthropometry | 1 | 1997 | 1350 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 1997 | 1660 | 0.010 |
Why?
|
Nutritional Status | 1 | 1997 | 1609 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 1997 | 7785 | 0.000 |
Why?
|